The KPNA2 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population featuring targeted disruption of the KPNA2 gene in the HeLa human cervical adenocarcinoma cell line. This loss-of-function model is designed for investigating nuclear import mechanisms and their implications in oncogenic signaling and viral replication.
HeLa cells are an HPV18-positive epithelial line with constitutive expression of the E6 and E7 oncoproteins, which degrade p53 and inactivate Rb, respectively, resulting in abrogated cell cycle checkpoints and a highly proliferative phenotype. This background provides a robust and well-characterized system for studying host-pathogen interactions and cancer cell biology.
KPNA2 encodes importin subunit alpha-2, a key adaptor of the classical nuclear import pathway that binds cargo proteins bearing a nuclear localization signal (NLS) and forms a ternary complex with importin beta (KPNB1). This complex translocates through the nuclear pore complex via interactions with nucleoporins such as NUP50 and NUP62, in a Ran GTPase-dependent manner. KPNA2 mediates nuclear import of transcription factors including NF-??B p65, STAT1, p53, and Rb, as well as the HPV E2 protein. Its expression is regulated by E2F1, c-Myc, and NF-??B, and is influenced by HPV E6/E7. Consequently, KPNA2 disruption blocks nuclear accumulation of these cargoes, impairing cell cycle progression (via indirect effects on cyclin B1), NF-??B transcriptional activity, and interferon signaling.
In HeLa cells, the HPV-driven environment co-opts nuclear transport to facilitate viral replication and sustain oncogenic transformation. Knockout of KPNA2 disrupts the nuclear import of HPV E2 and critical host factors, potentially attenuating viral processes and oncogenic signaling. This model is especially powerful for examining how aberrant nucleocytoplasmic trafficking contributes to cervical cancer pathogenesis, mitotic regulation, and therapeutic resistance.
Investigators can employ this knockout cell population to delineate cargo-specific import mechanisms, assess the role of KPNA2 in HPV replication and oncogenesis, and study its impact on cell cycle dynamics and drug response. Standard assays include Western blotting for KPNA2 and cargo localization, immunofluorescence, RT-qPCR, proliferation and cell cycle flow cytometry, RNA-seq, and migration/invasion evaluations. For additional information or technical support, please contact Ascent Research.
